| Filed On | Filing |
|---|---|
| 09 Oct 2026 | SCHEDULE 13G/A |
| 19 Aug 2026 |
Form 4: Petras Michael B. Jr., Director
Sold 294,515 shares ($5.45M) · Sold 850,000 shares ($15.7M) |
| 17 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 11 Aug 2026 |
Form 4: Rutz Michael P, President of Sterigenics
Sold 150,000 shares ($2.83M) |
| 07 Aug 2026 |
Form 4: Lyons Jonathan M., Sr. Vice President, CFO
Gave up 11,316 shares to cover exercise price or tax ($203K) |
| 07 Aug 2026 | 144 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 30 Jul 2026 | SCHEDULE 13G/A |
| 29 May 2026 | SD |
| 27 May 2026 |
Form 4: Klee Ann R., Director
Received 14,970 shares as a grant or award |
| 27 May 2026 |
Form 4: Shader Alton, Director
Received 375,939 shares as a grant or award · Received 203,634 shares as a grant or award · Granted 101,817 Share Appreciation Units |
| 27 May 2026 |
Form 3: Shader Alton, Director
No securities owned |
| 27 May 2026 |
Form 4: Kyle Richard G, Director
Received 14,970 shares as a grant or award |
| 27 May 2026 |
Form 4: Krause Kenneth D., Director
Received 14,970 shares as a grant or award |
| 27 May 2026 |
Form 4: Cunningham Sean Laurence, Director
Received 14,970 shares as a grant or award |
| 27 May 2026 |
Form 4: Flynn Karen, Director
Received 14,970 shares as a grant or award |
Loading...